易還財務投資(08079.HK)擬210萬港元出售香港飲食業務
格隆匯 3 月 24日丨易還財務投資(08079.HK)宣佈,於2021年3月24日,公司全資附屬元膳集團擬以210萬港元出售目標公司三本全部已發行股本,出售所得款項擬用作公司的一般營運資金。
據悉,標公司為一間於香港註冊成立之有限公司,併為賣方的附屬公司。目標公司主要於香港經營韓式餐廳業務。
董事會認為現時於香港經營飲食業務存在不確定因素及經營表現不及預期,而繼續運作飲食業務將佔用集團過多的資源,該等資源可用於其他更大有可為的業務。因此,董事會認為,透過出售目標公司,集團可將其資源重新集中於集團其他較強的業務部門。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.